A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111

Blood Vessels, Thrombosis & Hemostasis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles